Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT06310993
Eligibility Criteria:
Inclusion Criteria:
* Patients about to start or who are undergoing first line palliative immunotherapy for advanced, unresectable, or metastatic mesothelioma or patients about to start or who are undergoing first line palliative chemotherapy for advanced, unresectable, or metastatic pancreatic cancer.
* Age over 18 years old
* Histological or cytological diagnosis of mesothelioma or pancreatic cancer.
* ECOG Performance status 0-1 (to be assessed by clinician)
* Ability to provide informed consent
Exclusion Criteria:
* Prior treatment with systemic anti-cancer treatment
* More than one primary cancer
* Uncontrolled brain or bone metastases
* Patients who have progressed on first line palliative immunotherapy for advanced, unresectable, or metastatic mesothelioma.
* Patients who have progressed on first line palliative chemotherapy for advanced, unresectable, or metastatic pancreatic cancer.
* Patients with active co-morbidities that would prevent or limit their participation in the exercise intervention
* Age below 18 years old
* No histological or cytological diagnosis of mesothelioma or pancreatic cancer.
* ECOG Performance status of 2 or more
* Unable to provide informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06310993
Study Brief:
Protocol Section:
NCT06310993